JAG1 and breast cancer: In bone-metastatic BC, the activation of JAG1/Notch3 signaling induced by osteoblasts and osteoblast-derived TGF-β1 contributes to aggressive osteolytic metastasis and bone destruction in vivo (Zhang et al., 2010).